Affymax Stock

Affymax EBITDA per Employee

The EBITDA per Employee of Affymax (AFFY) as of Aug 7, 2026 is -9.50 M USD.

EBITDA per Employee

-9.50 MUSD

Last updated:

EBITDA per Employee of Affymax is 2026 -9.50 M USD. EBITDA per Employee of Affymax was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

EBITDA per Employee of Affymax is -9.50 M USD in 2026.

On Eulerpool you can find the complete historical development of EBITDA per Employee Affymax since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Affymax historically and in real time.

Access this data via the Eulerpool API

Workforce — Affymax

All Key Metrics — Affymax